Dianthus Therapeutics, Inc. /DE/ Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q2 2022 to Q3 2024.
  • Dianthus Therapeutics, Inc. /DE/ Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $17K, a 76.1% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $17K -$54K -76.1% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $27K Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $39K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $54K -$62K -53.4% Dec 31, 2023 10-K 2024-03-21
Q3 2023 $71K -$10.7M -99.3% Sep 30, 2023 10-Q 2023-11-09
Q4 2022 $116K Dec 31, 2022 8-K 2023-12-21
Q3 2022 $10.8M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $11.6M Jun 30, 2022 10-Q 2022-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.